Who
Ilan Levin
Director and 10% owner
Company insider
Files Form 4 as: Director and 10% owner, Silexion Therapeutics; 10% owner, Moringa Acquisition.
In numbers
- Trades disclosed
- 5
- Buys
- 2
- Sells
- 0
- Bought
- $3.5M
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 19 Feb 2021
- Last trade
- 15 Sep 2025
- Last filed
- 27 Jan 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Sep 2025filed 27 Jan 2026 | SLXN Silexion TherapeuticsBiotechnology | SEC FORM 4 Code A | $1.8M450,000 at $4.00 | filing |
| 7 Aug 2025filed 27 Jan 2026 | SLXN Silexion TherapeuticsBiotechnology | SEC FORM 4 Code J | —5,550 at $0.00 | filing |
| 7 Aug 2025filed 27 Jan 2026 | SLXN Silexion Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code J | —935 at $0.00 | filing |
| 3 Mar 2021filed 4 Mar 2021 | Moringa Acquisition | SEC FORM 4 Bought | $279K27,857 at $10.00 | filing |
| 19 Feb 2021filed 4 Mar 2021 | Moringa Acquisition | SEC FORM 4 Bought | $3.3M325,000 at $10.00 | filing |
News
No headline names them, or the companies they trade most, lately.